Evidence map›Paper›PMID 37958996›Full record

ReviewInternational journal of molecular sciences2023

Addressing Key Questions in Organoid Models: Who, Where, How, and Why?

María Gómez-Álvarez, Marcos Agustina-Hernández, Emilio Francés-Herrero, Adolfo Rodríguez-Eguren, Clara Bueno-Fernandez, Irene Cervelló

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

María Gómez-ÁlvarezInstituto de Investigación Sanitaria La Fe (IIS La Fe), IVI Foundation, IVIRMA Global Research Alliance, 46026 Valencia, Spain.ORCID 0009-0007-1862-5403
Marcos Agustina-HernándezInstituto de Investigación Sanitaria La Fe (IIS La Fe), IVI Foundation, IVIRMA Global Research Alliance, 46026 Valencia, Spain.ORCID 0000-0003-1025-8024
Emilio Francés-HerreroInstituto de Investigación Sanitaria La Fe (IIS La Fe), IVI Foundation, IVIRMA Global Research Alliance, 46026 Valencia, Spain.ORCID 0000-0002-5202-8967
Adolfo Rodríguez-EgurenInstituto de Investigación Sanitaria La Fe (IIS La Fe), IVI Foundation, IVIRMA Global Research Alliance, 46026 Valencia, Spain.ORCID 0000-0002-1266-8513
Clara Bueno-FernandezInstituto de Investigación Sanitaria La Fe (IIS La Fe), IVI Foundation, IVIRMA Global Research Alliance, 46026 Valencia, Spain.
Irene CervellóInstituto de Investigación Sanitaria La Fe (IIS La Fe), IVI Foundation, IVIRMA Global Research Alliance, 46026 Valencia, Spain.ORCID 0000-0002-7018-4971
Instituto de Investigación Sanitaria La Fe · ESUniversitat de València · ES

Funding

Generalitat Valenciana CIAPOT/2022/29Generalitat Valenciana CIPROM/2021/058Instituto de Salud Carlos III CP19/00149Instituto de Salud Carlos III PI21/00305Ministerio de Universidades FPU18/06327Ministerio de Universidades FPU19/04850Ministerio de Universidades FPU20/00251Ministerio de Universidades MS21-142
6 · The paper itself

Abstract

Organoids are three-dimensional cellular structures designed to recreate the biological characteristics of the body's native tissues and organs in vitro. There has been a recent surge in studies utilizing organoids due to their distinct advantages over traditional two-dimensional in vitro approaches. However, there is no consensus on how to define organoids. This literature review aims to clarify the concept of organoids and address the four fundamental questions pertaining to organoid models: (i) What constitutes organoids?-The cellular material. (ii) Where do organoids grow?-The extracellular scaffold. (iii) How are organoids maintained in vitro?-Via the culture media. (iv) Why are organoids suitable in vitro models?-They represent reproducible, stable, and scalable models for biological applications. Finally, this review provides an update on the organoid models employed within the female reproductive tract, underscoring their relevance in both basic biology and clinical applications.

Indexed as

OrganoidsCulture MediaFemaleHumansCulture Media3D culturebioengineeringfemale reproductionhydrogelorganoids

Identifiers

PMID37958996
PMCPMC10650475
OpenAlexW4388408457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.